Binder profile
ZINC390823133
Virtual-screening candidate from ZINC.
Bound to: PA5514 — beta-lactamase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC390823133- UniProt (similar protein)
I6YCI1- Tanimoto
- 0.551
- Target protein
- PA5514
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 390.5
- LogP ≤ 5 -0.96
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 141.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@@H](C)[C@H]12C[C@@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@@H](C)[C@H]12
InChI=1S/C14H22N4O5S2/c1-6-10-7(2)13(19)18(10)11(14(20)21)12(6)24-9-3-8(16-5-9)4-17-25(15,22)23/h6-10,16-17H,3-5H2,1-2H3,(H,20,21)(H2,15,22,23)/t6-,7-,8-,9-,10+/m0/s1InChI=1S/C14H22N4O5S2/c1-6-10-7(2)13(19)18(10)11(14(20)21)12(6)24-9-3-8(16-5-9)4-17-25(15,22)23/h6-10,16-17H,3-5H2,1-2H3,(H,20,21)(H2,15,22,23)/t6-,7-,8-,9-,10+/m0/s1
TZWKSYAJPCSFML-BQHMLIOBSA-NTZWKSYAJPCSFML-BQHMLIOBSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 4J6
- Homolog
- I6YCI1
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC390823133 →
- ZINC ZINC20 ZINC390823133 →
- UniProt UniProt I6YCI1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC390823133”) →
Other binders for this protein
Quick navigation to other ligands bound to PA5514.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 48
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).